Medicines appraisal cards

Medicines appraisal cards have been developed for the Guidelines audience to announce new recommendations from the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), and the All Wales Medicines Strategy Group (AWMSG)

Xeljanz SMC 30:07

Tofacitinib▼ (Xeljanz®) SMC2122, SMC1298/18, SMC2116

2019-04-24T07:29:00+01:00Commissioned by Pfizer Limited

Information intended for healthcare professionals only.

Xeljanz TA pic

Tofacitinib▼ (Xeljanz®) NICE TA547, TA480, TA543

2019-04-24T07:26:00+01:00Commissioned by Pfizer Limited

Information intended for healthcare professionals only.

Image of Xarelto SMC card (Sep 2019)

Xarelto® ▼ (rivaroxaban) SMC2128

2019-03-14T13:25:00+00:00Commissioned by Bayer

Information intended for healthcare professionals only.

Final version_Ozempic SMC card PI update

Semaglutide 0.25 mg, 0.5 mg and 1 mg solution for injection in pre-filled pen (Ozempic®▼) SMC No. (2092)

2019-02-11T12:51:00+00:00Funded by Novo Nordisk Limited

Information intended for healthcare professionals only.